Resumen acción SMSPHARMA
SMS Pharmaceuticals Limited fabrica y vende principios activos farmacéuticos (API) y productos intermedios en la India.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Competidores de SMS Pharmaceuticals Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | ₹207.40 |
| 52 Week High | ₹218.00 |
| 52 Week Low | ₹71.25 |
| Beta | 1.18 |
| 1 Month Change | 28.90% |
| 3 Month Change | 58.74% |
| 1 Year Change | 185.09% |
| 3 Year Change | 44.28% |
| 5 Year Change | 231.05% |
| Change since IPO | 477.31% |
Noticias y actualizaciones recientes
Recent updates
SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 25% Share Price Surge Not Quite Adding Up
Feb 29
SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment
Sep 24SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be ₹0.30
Sep 11SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 28SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Somewhat Strained Balance Sheet
Jun 07Shareholders May Not Be So Generous With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation And Here's Why
Sep 23SMS Pharmaceuticals (NSE:SMSPHARMA) Is Due To Pay A Dividend Of ₹0.30
Sep 15SMS Pharmaceuticals (NSE:SMSPHARMA) Will Pay A Dividend Of ₹0.30
Sep 01SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 18We Think SMS Pharmaceuticals (NSE:SMSPHARMA) Can Stay On Top Of Its Debt
Mar 22SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality
Jun 03Should You Be Adding SMS Pharmaceuticals (NSE:SMSPHARMA) To Your Watchlist Today?
Mar 08What Type Of Shareholders Make Up SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Registry?
Feb 22The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 185% And Shareholders Are Boasting About It
Feb 08SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 18
Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Meaningful Debt Burden
Dec 09Should You Take Comfort From Insider Transactions At SMS Pharmaceuticals Limited (NSE:SMSPHARMA)?
Nov 18The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 110% And Shareholders Are Boasting About It
Oct 28What Kind Of Shareholders Hold The Majority In SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Shares?
Oct 08Are Dividend Investors Getting More Than They Bargained For With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Dividend?
Sep 17SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Aug 26SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Price Could Signal Some Risk
Aug 08SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Business Is Trailing The Market But Its Shares Aren't
Aug 08SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Looks Just Right
Jul 25SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Price Matching Investor Opinion
Jul 07Rentabilidad de los accionistas
| SMSPHARMA | IN Pharmaceuticals | Mercado IN | |
|---|---|---|---|
| 7D | 11.2% | -0.2% | 1.1% |
| 1Y | 185.1% | 61.8% | 47.9% |
Rentabilidad frente al sector: SMSPHARMA superó al sector Indian Pharmaceuticals , que obtuvo un rendimiento del 30.2% el año pasado.
Rentabilidad vs. Mercado: SMSPHARMA superó al mercado Indian, que obtuvo un rendimiento del 19.4% el año pasado.
Volatilidad de los precios
| SMSPHARMA volatility | |
|---|---|
| SMSPHARMA Average Weekly Movement | 9.4% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.2% |
| 10% least volatile stocks in IN Market | 4.2% |
Precio estable de las acciones: SMSPHARMAha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: SMSPHARMA(8%) se ha mantenido estable durante el último año, pero sigue siendo superior al 75% de los valores de Indian.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1987 | 1,095 | Ramesh Potluri | https://www.smspharma.com |
SMS Pharmaceuticals Limited fabrica y vende principios activos farmacéuticos (API) y productos intermedios en la India. La empresa ofrece productos antiulcerosos, antimicóticos, antimigrañosos, antidiabéticos, antiepilépticos, antipsicóticos, antiinflamatorios, antimicóticos, antivirales, anticoagulantes y antirretrovirales. También participa en actividades de investigación por contrato.
Resumen de fundamentos de SMS Pharmaceuticals Limited
| Estadísticas fundamentales de SMSPHARMA | |
|---|---|
| Capitalización bursátil | ₹17.56b |
| Beneficios(TTM) | ₹360.58m |
| Ingresos (TTM) | ₹6.13b |
48.7x
Ratio precio-beneficio2.9x
Ratio precio-beneficio¿Está SMSPHARMA sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de SMSPHARMA | |
|---|---|
| Ingresos | ₹6.13b |
| Coste de los ingresos | ₹4.22b |
| Beneficio bruto | ₹1.91b |
| Otros gastos | ₹1.55b |
| Beneficios | ₹360.58m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 4.26 |
| Margen bruto | 31.16% |
| Margen de beneficio neto | 5.88% |
| Ratio deuda/patrimonio | 57.8% |
¿Cómo se ha desempeñado SMSPHARMA a largo plazo?
Ver rendimiento histórico y comparativa